Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: A subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene

Human Pathology

Volumn 35, Issue 10, 2004, Pages 1223-1230

  Sakurai, Shinji ^a,e   Hasegawa, Tadashi ^b   Sakuma, Yuji ^a   Takazawa, Yutaka ^c   Motegi, Atsushi ^d   Nakajima, Takashi ^d   Saito, Ken ^a   Fukayama, Masashi ^c   Shimoda, Tadakazu ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kawachi gun 329 0498 ^*  (Japan)

Author keywords

gastrointestinal stromal tumors; GISTs; ICCs; interstitial cells of Cajal; mast cell infiltration; myxoid epithelioid; PCR; PDGFRA; PDGFRA gene mutation; platelet derived growth factor receptor alpha; polymerase chain reaction

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; EOSINOPHIL; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MORPHOLOGY; NUCLEUS ACCUMBENS; TUMOR CELL;

ADULT; AGED; EPITHELIAL CELLS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STROMAL CELLS;

EID: 5444222014     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.008     Document Type: Article

References (31)

1. Mazur M.T., Clark H.B. Gastric stromal tumors reappraisal of histogenesis. Am J Surg Pathol. 7:1983;507-519
2. Ueyama T., Guo K.J., Hashimoto H., et al. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer. 69:1992;947-955
3. Franquemont D.W., Frierson H.F. Jr. Muscle differentiation and clinicopathological features of gastrointestinal stromal tumors. Am J Surg Pathol. 16:1992;947-954
4. Fletcher C.D., Berman J.J., Corless C., et al. Diagnosis of gastrointestinal stromal tumors a consensus approach. Hum Pathol. 33:2002;459-465
5. Miettinen M., Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 438:2001;1-12
6. Ward S.M., Burns A.J., Torihashi S., et al. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J Physiol. 480:1994;91-97
7. Burns A.J., Lomax A.E., Torihashi S., et al. Interstitial cells of Cajal mediate inhibitory neurotransmission in the stomach. Proc Natl Acad Sci U S A. 93:1996;12008-12013
8. Hirota S., Isozaki K., Yasuhiro M., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 279:1998;577-580
9. Sarlomo-Rikala M., Kovatich A.J., et al. CD117 a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 11:1998;728-734
10. Kindblom L.G., Remotti H.E., Aldenborg F., et al. Gastrointestinal pacemaker cell tumor (GIPACT) gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 152:1998;1259-1269
11. Sakurai S., Fukasawa T., Chong J.M., et al. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol. 154:1999;23-28
12. Tsujimura T., Makiishi-Shimobayashi C., Lundkvist J., et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol. 158:2001;817-823
13. Rubin B.P., Singer S., Tsao C., et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61:2001;8118-8121
14. Heinrich M.C., Corless C.L., Duensing A., et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 299:2003;708-710
15. Hirota S., Ohashi A., Nishida T., et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 125:2003;660-667
16. Wardelmann E., Neidt I., Bierhoff E., et al. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol. 15:2002;125-136
17. Hasegawa T., Matsuno Y., Shimoda T., et al. Gastrointestinal stromal tumor consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 33:2002;669-676
18. van Oosterom A.T., Judson I., Verweij J., et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors A phase I study. Lancet. 358:2001;1421-1423
19. Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 347:2002;472-480
20. Heinrich M.C., Corless C.L., Demetri G.D., et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 21:2003;4342-4349
21. Miettinen M., Sarlomo-Rikala M., Lasota J. Gastrointestinal stromal tumors recent advances in understanding of their biology. Hum Pathol. 30:1999;1213-1220
22. Maluf H.M., Gersell D.J. Uterine leiomyomas with high content of mast cells. Arch Pathol Lab Med. 118:1994;712-714
23. Yavuz E., Gulluoglu M.G., Akbas N., et al. The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Pathol Int. 51:2001;938-941
24. Ueda T., Aozasa K., Tsujimoto M., et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer. 62:1988;2416-2419
25. Tomita Y., Aozasa K., Myoui A., et al. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer. 54:1993;194-199
26. Debiec-Rychter M., Wasag B., Stul M., et al. Gastrointestinal stromal tumors (GISTs) negative for KIT (CD 117 antigen) immunoreactivity. J Pathol. 202:2004;430-438
27. Ward S.M., Ordog T., Bayguinov J.R., et al. Development of interstitial cells of Cajal and pacemaking in mice lacking enteric nerves. Gastroenterology. 117:1999;584-594
28. Wu J.J., Rothman T.P., Gershon M.D. Development of the interstitial cell of Cajal Origin, Kit dependence and neuronal and nonneuronal sources of Kit ligand. J Neurosci Res. 59:2000;384-401
29. Torihashi S., Horisawa M., Watanabe Y. c-kit immunoreactive interstitial cells in the human gastrointestinal tract. J Auton Nerv Syst. 75:1999;38-50
30. Vanderwinden J.M., Rumessen J.J., de Kerchove d'Exaerde A. Jr, et al. Kit-negative fibroblast-like cells expressing SK3, a Ca2+-activated K+ channel, in the gut musculature in health and disease. Cell Tissue Res. 310:2002;349-358
31. Fujita A., Takeuchi T., Jun H., Hata F. Localization of Ca2+-activated K+ channel, SK3, in fibroblast-like cells forming gap junctions with smooth muscle cells in the mouse small intestine. J Pharmacol Sci. 92:2003;35-42